Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FWAEQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,082.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,082.93 to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants, a subdermal contraceptive device. The award, issued on August 22, 2025, with completion targeted for September 15, 2025, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, Illinois. This delivery order is issued under the company's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Defense Department healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract awards from the Defense Logistics Agency covering prescription medications, biologics, vaccines, and specialized medical consumables. The company's federal contracting history demonstrates particular strength in delivering pharmaceutical products to military health facilities on a nationwide basis. Under its substantial IDC with DLA, the company provides both branded and generic prescription drugs, over-the-counter medications, and medical devices across multiple therapeutic categories, positioning it as a key vendor for military healthcare logistics and pharmacy operations.
Quick answers
Who was awarded contract SPE2DB25FWAEQ?
SPE2DB25FWAEQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FWAEQ worth?
The government has obligated $2,083 on SPE2DB25FWAEQ.
Is contract SPE2DB25FWAEQ an order under another contract?
Yes. SPE2DB25FWAEQ is a delivery order under SPE2DB25D9322, an indefinite delivery contract.
Was contract SPE2DB25FWAEQ competed?
The extent of competition for SPE2DB25FWAEQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award